This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Stroke is currently one of the most devastating public health problems. It is the third leading cause of death and the leading cause of serious long-term disability in the United States. It affects an estimated 700,000 persons each year, and only about two-thirds of those with a new or recurrent stroke survive. Unfortunately, lingering motor and cognitive deficits that often accompany a stroke can be demoralizing to the survivors, relegating many productive individuals to the role of dependent. The costs associated with the acute treatment, long-term care, and lost productivity of stroke survivors are a significant burden to the individual and to society. These concerns have provided the impetus for extensive research efforts to clarify the causes and pathophysiology of stroke and to develop effective acute and preventive interventions. The status of these efforts was addressed recently by stroke experts at the Second Annual Advances in Stroke Management conference. This supplement presents an overview of those proceedings.
Evidence that platelets play an integral role in the pathophysiology of thromboembolic stroke is indisputable. Platelets normally contribute to clot formation and vascular repair. However, under pathologic conditions they participate in the formation of vascular-occluding thrombi and emboli. Therefore, acute and preventive treatments focus on platelets and other elements of the coagulation system.
Cardiac disease and atherosclerotic cerebrovascular disease leading to stroke are often coincident. In fact, stroke patients …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
